Gain Therapeutics Inc (GANX) revealed Loss for full year of -$20.40 million
The company's bottom line came in at -$20.40 million, or -$0.89 per share. This compares with -$22.30 million, or -$1.71 per share, last year.
Gain Therapeutics Inc earnings at a glance (GAAP) :
-Earnings: -$20.40 Mln. vs. -$22.30 Mln. last year.
-EPS: -$0.89 vs. -$1.71 last year.
For comments and feedback: editorial@rttnews.com